NEOGENOMICS INC's ticker is and the CUSIP is 64049MAA8. A total of 21 filers reported holding NEOGENOMICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $15,685,000 | -65.7% | 18,386,000 | -52.4% | 0.15% | -64.1% |
Q4 2021 | $45,773,000 | -20.1% | 38,648,000 | 0.0% | 0.43% | -13.8% |
Q3 2021 | $57,264,000 | +1.4% | 38,648,000 | -2.5% | 0.49% | +14.9% |
Q2 2021 | $56,476,000 | -4.7% | 39,648,000 | +0.1% | 0.43% | -14.2% |
Q1 2021 | $59,277,000 | +10.3% | 39,618,000 | +19.6% | 0.50% | +26.8% |
Q4 2020 | $53,723,000 | +62.5% | 33,113,000 | +24.8% | 0.40% | +34.4% |
Q3 2020 | $33,056,000 | +125.9% | 26,530,000 | +96.1% | 0.29% | +100.0% |
Q2 2020 | $14,634,000 | – | 13,530,000 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opti Capital Management, LP | 15,750,000 | $13,592,000 | 1.09% |
Context Capital Management, LLC | 13,000 | $11,214,000 | 0.73% |
ADVENT CAPITAL MANAGEMENT /DE/ | 19,422,000 | $16,659,000 | 0.27% |
WOLVERINE ASSET MANAGEMENT LLC | 18,386,000 | $15,685,000 | 0.15% |
Aequim Alternative Investments LP | 3,500,000 | $3,019,000 | 0.08% |
LINDEN ADVISORS LP | 12,066,000 | $10,358,000 | 0.06% |
CAPSTONE INVESTMENT ADVISORS, LLC | 23,500,000 | $20,269,000 | 0.06% |
LAZARD ASSET MANAGEMENT LLC | 15,000,000 | $12,937,000 | 0.02% |
D. E. Shaw & Co., Inc. | 16,900,000 | $14,517,000 | 0.01% |
BNP PARIBAS FINANCIAL MARKETS | 10,323,000 | $8,800,358,000 | 0.01% |